Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNTX Context Therapeutics Inc.

已收盘 12-19 16:00:00 EST

1.09

-0.13

-10.66%

盘后1.11

+0.02+1.83%

17:51 EST

最高1.23	最低1.08	成交量26.42万
今开1.23	昨收1.22	日振幅12.30%
总市值8,175万	流通市值4,246万	总股本7,500万
成交额29.65万	换手率0.68%	流通股本3,895万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNTX","market":"US","secType":"STK","nameCN":"Context Therapeutics Inc.","latestPrice":1.09,"timestamp":1734642000000,"preClose":1.22,"halted":0,"volume":264155,"hourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.09,"latestTime":"17:51 EST","volume":590,"amount":639.52,"timestamp":1734648708023},"delay":0,"floatShares":38951625,"shares":74998312,"eps":-0.719189,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.13,"latestTime":"12-19 16:00:00 EST","open":1.23,"high":1.23,"low":1.08,"amount":296476.71523,"amplitude":0.122951,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.719189,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734685200000},"adr":0,"listingDate":1634702400000,"adjPreClose":1.22,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.09,"latestTime":"17:51 EST","volume":590,"amount":639.52,"timestamp":1734648708023},"volumeRatio":0.904431},"requestUrl":"/m/hq/s/CNTX","defaultTab":"news","newsList":[{"id":"2492510965","title":"Context Therapeutics Inc.盘中异动 大幅跳水6.62%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492510965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492510965?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:42","pubTimestamp":1734446571,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时42分，Context Therapeutics Inc.股票出现异动，股价快速下跌6.62%。截至发稿，该股报1.27美元/股，成交量5.6728万股，换手率0.08%，振幅6.62%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Portage Biotech Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Portage Biotech Inc.、Polyrizon Ltd.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为1489.94%、89.20%、18.07%，振幅较大的相关个股有Portage Biotech Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为46.46%、23.99%、21.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224251984c9086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224251984c9086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2491330083","title":"Context Therapeutics Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491330083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491330083?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:12","pubTimestamp":1734027151,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时12分，Context Therapeutics Inc.股票出现波动，股价急速下跌5.33%。截至发稿，该股报1.42美元/股，成交量7.5084万股，换手率0.10%，振幅5.33%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.13%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213021231ab730c7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213021231ab730c7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2486875207","title":"Context Therapeutics Inc.盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486875207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486875207?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:32","pubTimestamp":1732721536,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时32分，Context Therapeutics Inc.股票出现异动，股价大幅拉升5.44%。截至发稿，该股报1.55美元/股，成交量2.0735万股，换手率0.03%，振幅4.08%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112723321798e44f6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112723321798e44f6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2485615132","title":"Context Therapeutics Inc.盘中异动 股价大跌8.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485615132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485615132?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:32","pubTimestamp":1732285921,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时32分，Context Therapeutics Inc.股票出现异动，股价快速下跌8.51%。截至发稿，该股报1.37美元/股，成交量9.608万股，换手率0.13%，振幅2.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃，换手率分别为518.60%、62.48%、36.78%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.、Exicure, Inc.，振幅分别为19.38%、14.78%、10.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223201abd7921d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223201abd7921d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2484677456","title":"Context Therapeutics Inc.盘中异动 早盘大幅下跌5.98%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677456?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:27","pubTimestamp":1731943621,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时27分，Context Therapeutics Inc.股票出现异动，股价快速下挫5.98%。截至发稿，该股报1.73美元/股，成交量5.6554万股，换手率0.08%，振幅4.63%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232701abccc689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232701abccc689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CNTX","LENZ"],"gpt_icon":0},{"id":"2483412306","title":"Context Therapeutics Inc.2024财年第三财季实现净利润-17.46百万美元，同比减少197.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483412306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483412306?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686436,"startTime":"0","endTime":"0","summary":"11月16日，Context Therapeutics Inc.公布财报，公告显示公司2024财年第三财季净利润为-17.46百万美元，同比减少197.44%；其中营业收入为0.00美元，每股基本收益为-0.22美元。机构评级：截至2024年11月16日，当前有4家机构对Context Therapeutics Inc.目标价做出预测，其中目标均价为7.38美元，其中最低目标价为4.50美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000342a23b8a03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000342a23b8a03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX"],"gpt_icon":0},{"id":"2481158881","title":"Context Therapeutics Inc.盘中异动 急速下挫5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481158881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481158881?lang=zh_cn&edition=full","pubTime":"2024-11-08 03:18","pubTimestamp":1731007086,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日03时18分，Context Therapeutics Inc.股票出现异动，股价大幅下挫5.86%。截至发稿，该股报2.09美元/股，成交量6.1656万股，换手率0.08%，振幅6.31%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108031806abaafc64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108031806abaafc64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2477634001","title":"Context Therapeutics Inc.盘中异动 早盘股价大涨5.38%报2.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477634001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477634001?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:48","pubTimestamp":1729777708,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时48分，Context Therapeutics Inc.股票出现波动，股价急速上涨5.38%。截至发稿，该股报2.35美元/股，成交量23.9554万股，换手率0.32%，振幅5.36%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024214828971a2123&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024214828971a2123&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CNTX"],"gpt_icon":0},{"id":"2477653847","title":"Context Therapeutics Inc.股价拉升24.00% 市值涨4463.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477653847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477653847?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690265,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分，Context Therapeutics Inc.股票出现异动，股价快速上涨24.00%。截至发稿，该股报2.48美元/股，成交量27.9588万股，换手率0.37%，振幅6.50%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321310595bd4285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321310595bd4285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2475910976","title":"Context Therapeutics Inc.盘中异动 急速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475910976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475910976?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:35","pubTimestamp":1729092959,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时35分，Context Therapeutics Inc.股票出现异动，股价急速上涨5.13%。截至发稿，该股报2.05美元/股，成交量4.6173万股，换手率0.06%，振幅2.57%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016233559971a0aa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016233559971a0aa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2475955685","title":"Context Therapeutics Inc.盘中异动 早盘快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475955685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475955685?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:47","pubTimestamp":1729000074,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时47分，Context Therapeutics Inc.股票出现波动，股价大幅上涨5.03%。截至发稿，该股报2.09美元/股，成交量3.6982万股，换手率0.05%，振幅4.02%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101521475498e3c8b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101521475498e3c8b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2472429646","title":"Context Therapeutics Inc.盘中异动 股价大涨5.82%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472429646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472429646?lang=zh_cn&edition=full","pubTime":"2024-10-04 02:03","pubTimestamp":1727978636,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日02时03分，Context Therapeutics Inc.股票出现异动，股价大幅上涨5.82%。截至发稿，该股报2.00美元/股，成交量1.1421万股，换手率0.02%，振幅3.70%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.79%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040203569719e3bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040203569719e3bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2460244861","title":"Context Therapeutics Inc.2024财年第二财季实现净利润-2.25百万美元，同比增加55.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460244861","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460244861?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824037,"startTime":"0","endTime":"0","summary":"8月17日，Context Therapeutics Inc.公布财报，公告显示公司2024财年第二财季净利润为-2.25百万美元，同比增加55.09%；其中营业收入为0.00美元，每股基本收益为-0.04美元。机构评级：截至2024年8月17日，当前有3家机构对Context Therapeutics Inc.目标价做出预测，其中目标均价为6.83美元，其中最低目标价为4.50美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006109f31b156&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006109f31b156&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX"],"gpt_icon":0},{"id":"2459101531","title":"Context Therapeutics Inc.盘中异动 临近午盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459101531","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459101531?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:34","pubTimestamp":1723649685,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时34分，Context Therapeutics Inc.股票出现异动，股价大幅上涨5.02%。截至发稿，该股报2.51美元/股，成交量4.5057万股，换手率0.06%，振幅6.69%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423344698e34f3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423344698e34f3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2458914955","title":"Context Therapeutics Inc.盘中异动 早盘快速下挫5.42%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458914955","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458914955?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:10","pubTimestamp":1723212620,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日22时10分，Context Therapeutics Inc.股票出现波动，股价大幅下挫5.42%。截至发稿，该股报2.27美元/股，成交量3.6146万股，换手率0.05%，振幅8.30%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.48%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为48.58%、46.97%、16.85%，振幅较大的相关个股有Cingulate Inc.、An2 Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.，振幅分别为34.60%、22.48%、22.42%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809221020af96d45f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809221020af96d45f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2457977563","title":"Context Therapeutics Inc.盘中异动 股价大跌9.17%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457977563","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457977563?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:34","pubTimestamp":1722864842,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时34分，Context Therapeutics Inc.股票出现波动，股价急速跳水9.17%。截至发稿，该股报2.08美元/股，成交量2230股，换手率0.00%，振幅5.68%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.84%。其相关个股中，Zevra Therapeutics, Inc.、Cervomed Inc.、Okyo Pharma Ltd Com Npv 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为998.74%、39.48%、13.57%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Vor Biopharma Inc.、Compass Therapeutics, Inc.，振幅分别为17.59%、13.04%、12.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052134029f10700d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052134029f10700d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CNTX","LENZ"],"gpt_icon":0},{"id":"2452361430","title":"Context Therapeutics Inc.盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452361430","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452361430?lang=zh_cn&edition=full","pubTime":"2024-07-19 01:43","pubTimestamp":1721324626,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日01时43分，Context Therapeutics Inc.股票出现异动，股价快速拉升5.25%。截至发稿，该股报2.15美元/股，成交量5.7311万股，换手率0.08%，振幅5.39%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.66%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Silo Pharma, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为2614.87%、2505.56%、1273.97%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190143469681e214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190143469681e214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CNTX","BK4139"],"gpt_icon":0},{"id":"2452161326","title":"Context Therapeutics Inc.盘中异动 临近午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452161326","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452161326?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:36","pubTimestamp":1721230565,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时36分，Context Therapeutics Inc.股票出现异动，股价快速下跌5.08%。截至发稿，该股报2.08美元/股，成交量4.22万股，换手率0.06%，振幅5.53%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为2.04%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233605af92cd11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233605af92cd11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2450845618","title":"HC Wainwright &amp; Co.：重申Context Therapeutics(CNTX.US)评级，由买入调整至买入评级, 目标价由5.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450845618","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450845618?lang=zh_cn&edition=full","pubTime":"2024-07-11 01:13","pubTimestamp":1720631596,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LENZ","CNTX","BK4007"],"gpt_icon":0},{"id":"2450809812","title":"BUZZ-以 375 万美元收购实验性癌症疗法后，Context Therapeutics 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2450809812","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450809812?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:33","pubTimestamp":1720625621,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月10日 - ** Context Therapeutics   股价上涨2.8%至2.00美元 ** 药物开发商称已从私人控股的 Link Immunotherapeutics 公司获得一种实验性癌症疗法** CNTX 一次性支付了 375 万美元** 公司将于 2025 年第一季度开始 CT-95 疗法的早期试验** 截至目前，股价上涨 77.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BUZZ","BK4139","BK4007","CNTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.contexttherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1867},{"period":"1month","weight":-0.2738},{"period":"3month","weight":-0.4529},{"period":"6month","weight":-0.4352},{"period":"1year","weight":0.2079},{"period":"ytd","weight":0.0796}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Context Therapeutics Inc.于2015年4月在特拉华州成立。这是一家临床阶段的生物制药公司，致力于改善罹患癌症的妇女的生活。肿瘤学药物开发的深远进展扩大了癌症女性可获得的治疗选择，但是治疗耐药性和复发继续限制了此类治疗的功效和持续时间。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.098696},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.078123},{"month":3,"riseRate":0.666667,"avgChangeRate":0.031637},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.107992},{"month":5,"riseRate":1,"avgChangeRate":0.504922},{"month":6,"riseRate":0.666667,"avgChangeRate":0.266045},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.114577},{"month":8,"riseRate":0.666667,"avgChangeRate":0.026866},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.051007},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.016878},{"month":11,"riseRate":0.5,"avgChangeRate":-0.052796},{"month":12,"riseRate":0.25,"avgChangeRate":-0.25227}],"exchange":"NASDAQ","name":"Context Therapeutics Inc.","nameEN":"Context Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Context Therapeutics Inc.,CNTX,Context Therapeutics Inc.股票,Context Therapeutics Inc.股票老虎,Context Therapeutics Inc.股票老虎国际,Context Therapeutics Inc.行情,Context Therapeutics Inc.股票行情,Context Therapeutics Inc.股价,Context Therapeutics Inc.股市,Context Therapeutics Inc.股票价格,Context Therapeutics Inc.股票交易,Context Therapeutics Inc.股票购买,Context Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}